Description
Antenatal hydronephrosis is one of the most frequently detected fetal anomalies on prenatal ultrasound, requiring a structured approach to evaluation and follow-up. This session will provide a practical overview of its prenatal diagnosis, risk stratification, postnatal assessment, and evidence-based management. Experts will discuss when to reassure, when to investigate further, and when timely intervention is warranted. Designed for clinicians, the session aims to enhance confidence in delivering optimal care through real-world clinical insights.
Summary Listen
- Antenatal hydronephrosis affects 1 to 5 percent of pregnancies, necessitating a precise approach to differentiate transient physiological dilatation from significant pathology like posterior urethral valves, high-grade vesicoureteral reflux, or obstruction. The majority of mild cases resolve spontaneously, while severe cases carry risks of renal parenchymal loss, pulmonary hypoplasia, and end-stage kidney disease. Mastery of the Urinary Tract Dilation classification system is essential, as it provides a standardized framework for risk stratification that outperforms older grading systems.
- Clinical accuracy begins with rigorous technique in measuring the anterior-posterior renal pelvic diameter. Clinicians must identify the widest diameter in the transverse plane, avoiding the narrow extra-renal segments and including only the pelvic diameter to prevent systematic misclassification. Initial postnatal ultrasounds should be deferred until 48 hours of age to account for physiologic diuresis, with the notable exception of cases involving red flags such as bilateral severe disease, oligohydramnios, or the keyhole sign, which require urgent multidisciplinary evaluation.
- Diagnostic management should favor selective imaging over routine protocols. Per 2025 European Association of Urology guidelines, routine continuous antibiotic prophylaxis is not supported by evidence for low-risk cases; its use should be reserved for high-risk subgroups such as those with recurrent febrile urinary tract infections or high-grade vesicoureteral reflux. Surgical intervention is indicated primarily by functional decline on diuretic renography, progressive dilatation, or clinical symptoms, rather than isolated imaging appearance.
- For the management of posterior urethral valves and other obstructive uropathies, fetal intervention remains limited to highly selected cases within specialized centers due to significant procedural risks and uncertain long-term outcomes. The clinical priority is a coordinated, multidisciplinary pathway involving pediatric urology, nephrology, and maternal-fetal medicine to ensure consistent, evidence-based care. Establishing institutional registries and structured transition programs for adolescents is crucial for long-term renal health. By moving away from over-investigation of low-risk patients and focusing on rigorous, system-based surveillance for high-risk cohorts, clinicians can optimize outcomes, mitigate parental anxiety, and preserve renal function in this vulnerable population.
Sample Certificate
About the Speakers
Dr. Vivek Vishwanathan
Consultant Pediatric Urologist, Dhiraj Hospital, Vadodara Assistant Professor, Sumandeep Vidyapeeth, Vadodara
Financial Disclosure
Comments
Comments
You must be logged in to leave a comment.